Page last updated: 2024-08-22

sizofiran and Local Neoplasm Recurrence

sizofiran has been researched along with Local Neoplasm Recurrence in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (40.00)	18.7374
1990's	3 (60.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukase, S; Kimura, Y; Takeda, K; Tojima, H	1
Goto, S; Kera, J; Sakai, S; Soma, GI; Suma, Y; Takeuchi, S	1
Korbelik, M; Krosl, G	1
Fujimoto, S	1
Chihara, T; Fujiwara, A; Fukuda, T; Goto, S; Ichinohe, K; Jimi, S; Kasamatsu, T; Kawai, N; Okamura, K; Suzuki, M	1

Trials

3 trial(s) available for sizofiran and Local Neoplasm Recurrence

Article	Year
Clinical evaluation of sizofilan as assistant immunotherapy in treatment of head and neck cancer. Acta oto-laryngologica. Supplementum, 1994, Volume: 511 Topics: Adult; Aged; CD4-Positive T-Lymphocytes; Combined Modality Therapy; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Injections, Intramuscular; Leukocyte Count; Lymphocyte Subsets; Lymphocytes; Male; Middle Aged; Neoplasm Proteins; Neoplasm Recurrence, Local; Sizofiran; Survival Rate; T-Lymphocytes, Helper-Inducer	1994
[Clinical efficacies of schizophyllan (SPG) on advanced gastric cancer]. Nihon Geka Gakkai zasshi, 1989, Volume: 90, Issue:9 Topics: Glycosaminoglycans; Humans; Neoplasm Recurrence, Local; Sizofiran; Stomach Neoplasms; Survival Rate	1989
Clinical evaluation of schizophyllan combined with irradiation in patients with cervical cancer. A randomized controlled study. Cancer, 1986, Aug-15, Volume: 58, Issue:4 Topics: Actuarial Analysis; Aged; Combined Modality Therapy; Drug Administration Schedule; Drug Evaluation; Female; Glycosaminoglycans; Humans; Leukocyte Count; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Random Allocation; Sizofiran; Uterine Cervical Neoplasms	1986

Other Studies

2 other study(ies) available for sizofiran and Local Neoplasm Recurrence

Article	Year
A case report of recurrent cervical cancer which responded to a combination of biological therapies. European journal of gynaecological oncology, 1994, Volume: 15, Issue:3 Topics: Adult; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Immunologic Factors; Lentinan; Lymphocytes, Tumor-Infiltrating; Neoplasm Recurrence, Local; Neoplasm Staging; Sizofiran; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms	1994
Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG). Cancer letters, 1994, Aug-29, Volume: 84, Issue:1 Topics: Animals; Carcinoma, Squamous Cell; Cell Death; Cell Migration Inhibition; Clone Cells; Combined Modality Therapy; Concanavalin A; Cytokines; Disease Models, Animal; Female; Hematoporphyrin Derivative; Immunotherapy; Leukocytes; Lung Neoplasms; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Recurrence, Local; Neoplasm Transplantation; Photochemotherapy; Sizofiran; Tumor Cells, Cultured	1994

Article

Year

A case report of recurrent cervical cancer which responded to a combination of biological therapies.

European journal of gynaecological oncology, 1994, Volume: 15, Issue:3

Topics: Adult; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Immunologic Factors; Lentinan; Lymphocytes, Tumor-Infiltrating; Neoplasm Recurrence, Local; Neoplasm Staging; Sizofiran; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms

1994

Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG).

Cancer letters, 1994, Aug-29, Volume: 84, Issue:1

Topics: Animals; Carcinoma, Squamous Cell; Cell Death; Cell Migration Inhibition; Clone Cells; Combined Modality Therapy; Concanavalin A; Cytokines; Disease Models, Animal; Female; Hematoporphyrin Derivative; Immunotherapy; Leukocytes; Lung Neoplasms; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Recurrence, Local; Neoplasm Transplantation; Photochemotherapy; Sizofiran; Tumor Cells, Cultured

1994